New immunotherapy shows promise in Hard-to-Treat colorectal cancer
Disease control
Ongoing
This study tests a new immunotherapy drug, HX008, against standard chemotherapy for people with a specific type of advanced colorectal cancer (MSI-H/dMMR). The goal is to see if HX008 can slow cancer growth better than chemo. About 190 adults with this cancer type will be randoml…
Phase: PHASE3 • Sponsor: Taizhou Hanzhong biomedical co. LTD • Aim: Disease control
Last updated May 15, 2026 11:55 UTC